NPS Pharmaceuticals was forced to slash its workforce by more than half yesterday after failing to win US approval for its lead drug for osteoporosis, even though the product is already on the market ...
PARSIPPANY, N.J., Sept. 19 NPS Pharmaceuticals,Inc. (Nasdaq: NPSP) announced today that the U.S. Food and DrugAdministration's Office of Orphan Products Development has granted orphan drugdesignation ...
EQS-Ad-hoc: PREOS Global Office Real Estate & Technology AG / Key word(s): Strategic Company Decision PREOS Global Office Real Estate & Technology AG supports as majority shareholder the planned ...
EQS-News: PREOS Global Office Real Estate & Technology AG / Key word(s): Real Estate PREOS Global Office Real Estate & Technology AG: WiredScore upgrades for 'The Centurion' and 'Access Tower' in ...
LEIPZIG, GERMANY / ACCESSWIRE / February 5, 2021 / PREOS Global Office Real Estate & Technology AG (FRA:PAG)(XETRA:PAG). Frederik Mehlitz, CEO of PREOS "The Essen transaction is a showcase deal for ...
PARSIPPANY, N.J., Sept. 19 -- NPS Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration's Office of Orphan Products Development has granted orphan drug designation to ...
- Luxembourg-based investment company with its own investor consortium of established European insurance companies to become new majority shareholder of publity Group subsidiary PREOS - Sales and ...
SAN FRANCISCO (MarketWatch) -- NPS Pharmaceuticals Inc. on Friday said the Food and Drug Administration has determined that the company's new drug application for Preos is approvable. The FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results